Walgreens Boots Alliance (WBA) Rating Reiterated by Robert W. Baird

Walgreens Boots Alliance (NASDAQ:WBA)‘s stock had its “buy” rating reaffirmed by Robert W. Baird in a research note issued to investors on Thursday. They currently have a $82.00 price objective on the pharmacy operator’s stock. Robert W. Baird’s target price indicates a potential upside of 14.53% from the stock’s previous close.

Several other research firms also recently issued reports on WBA. Royal Bank of Canada assumed coverage on shares of Walgreens Boots Alliance in a report on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price objective for the company. Needham & Company LLC reaffirmed a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a report on Saturday, September 16th. BidaskClub downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. Jefferies Group reaffirmed a “buy” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, September 7th. Finally, Raymond James Financial reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. Walgreens Boots Alliance presently has an average rating of “Buy” and a consensus target price of $86.70.

Shares of Walgreens Boots Alliance (WBA) traded down $3.91 on Thursday, hitting $71.60. 12,456,049 shares of the stock traded hands, compared to its average volume of 6,190,000. Walgreens Boots Alliance has a 52 week low of $63.82 and a 52 week high of $88.00. The firm has a market cap of $70,910.00, a price-to-earnings ratio of 18.94, a price-to-earnings-growth ratio of 1.34 and a beta of 1.22. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.24 by $0.04. The company had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. Walgreens Boots Alliance’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.10 EPS. research analysts anticipate that Walgreens Boots Alliance will post 5.54 EPS for the current year.

Walgreens Boots Alliance declared that its board has approved a share repurchase program on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s board believes its shares are undervalued.

In other Walgreens Boots Alliance news, Director John Anthony Lederer acquired 20,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, October 26th. The stock was bought at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is currently owned by company insiders.

Several large investors have recently added to or reduced their stakes in the company. Atlantic Trust Group LLC increased its position in shares of Walgreens Boots Alliance by 300.1% during the 3rd quarter. Atlantic Trust Group LLC now owns 1,046,190 shares of the pharmacy operator’s stock worth $80,787,000 after purchasing an additional 784,677 shares in the last quarter. Parametric Portfolio Associates LLC increased its position in shares of Walgreens Boots Alliance by 6.5% during the 3rd quarter. Parametric Portfolio Associates LLC now owns 1,821,794 shares of the pharmacy operator’s stock worth $140,679,000 after purchasing an additional 110,811 shares in the last quarter. AXA increased its position in shares of Walgreens Boots Alliance by 12.4% during the 3rd quarter. AXA now owns 320,262 shares of the pharmacy operator’s stock worth $24,731,000 after purchasing an additional 35,267 shares in the last quarter. Burgundy Asset Management Ltd. increased its position in shares of Walgreens Boots Alliance by 0.6% during the 3rd quarter. Burgundy Asset Management Ltd. now owns 5,475,196 shares of the pharmacy operator’s stock worth $422,795,000 after purchasing an additional 33,889 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC acquired a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth about $492,000. 61.18% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This news story was first posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was stolen and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this news story can be read at https://www.americanbankingnews.com/2018/01/04/walgreens-boots-alliance-wba-rating-reiterated-by-robert-w-baird.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply